DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Brazil
  • /
  • Consumer Retailing
Author Program NEWCreate Narrative
PGMN3 logo

Empreendimentos Pague Menos S.A. Stock Price

BOVESPA:PGMN3 Community·R$2.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PGMN3 Share Price Performance

R$3.73
-0.15 (-3.87%)
​
R$6.94
Fair Value
R$3.73
-0.15 (-3.87%)
46.2% undervalued intrinsic discount
R$6.94
Fair Value
Price R$3.73
AnalystConsensusTarget R$6.94
AnalystLowTarget R$5.00
AnalystHighTarget R$10.00
Sun, 9 Aug 26
Fair ValueR$6.94
Share Pricen/a

PGMN3 Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value R$6.94 46.2% undervalued intrinsic discount

Pharmaceutical Retail And Digital Channels Will Expand Market Reach

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value R$5 25.4% undervalued intrinsic discount

Brazil Retail Will Falter Amid Digital Competition

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value R$10 62.7% undervalued intrinsic discount

Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
PGMN3 logo
Empreendimentos Pague Menos
46.2% undervalued intrinsic discount

Pharmaceutical Retail And Digital Channels Will Expand Market Reach

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 9 Aug
Read Narrative
PGMN3 logo
Empreendimentos Pague Menos
25.4% undervalued intrinsic discount

Brazil Retail Will Falter Amid Digital Competition

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 25 Jul
Read Narrative
PGMN3 logo
Empreendimentos Pague Menos
62.7% undervalued intrinsic discount

Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 19 Mar
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
PGMN3 logo

PGMN3: Future Governance Decisions Are Expected To Support Share Price Upside

Fair Value: R$6.94 46.2% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
PGMN3 logo

PGMN3: Sustainability Index Inclusion Will Support Future Re-Rating Potential

Fair Value: R$5 25.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
PGMN3 logo

PGMN3: Follow On Offering At R$6.55 Will Support Further Upside Potential

Fair Value: R$10 62.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

4 Risks
4 Rewards
View Full Analysis

Empreendimentos Pague Menos S.A. Key Details

R$15.6b

Revenue

R$10.6b

Cost of Revenue

R$5.1b

Gross Profit

R$4.7b

Other Expenses

R$328.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.46
32.30%
2.10%
46.2%
View Full Analysis

About PGMN3

Founded
1981
Employees
28534
CEO
Jonas Neto
WebsiteView website
www.paguemenos.com.br

Empreendimentos Pague Menos S.A. engages in the retail sale of medicines, perfumeries, and personal hygiene and beauty products in Brazil. The company offers medicines and health care products; personal hygiene products, including deodorant, intimate care, and oral hygiene; foot, hair, face, and hand care products; dermo and beauty products; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. The company also offers vaccines, clinical analysis tests, and basic health services; clothing and accessories, supplements, first aid, food and drinks, chocolates, ice creams, popsicles, toys, pet and home products, laptop accessories, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. It sells its products through retail stores and online. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is based in Fortaleza, Brazil.

Recent PGMN3 News & Updates

User avatar
Narrative Update • Aug 09

PGMN3: Future Governance Decisions Are Expected To Support Share Price Upside

Analysts have reduced their price target for Empreendimentos Pague Menos to R$6.94 from R$7.83. This reflects updated assumptions that include a slightly higher discount rate, more measured revenue growth expectations, a modestly stronger profit margin profile, and a lower future P/E multiple.

Recent updates

No updates

Empreendimentos Pague Menos S.A. Competitors

RADL3 logo

Raia Drogasil

Symbol: BOVESPA:RADL3
Market cap: R$34.3b
ASAI3 logo

Sendas Distribuidora

Symbol: BOVESPA:ASAI3
Market cap: R$12.3b
GMAT3 logo

Grupo Mateus

Symbol: BOVESPA:GMAT3
Market cap: R$10.9b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide